Wellington Management Group LLP Keros Therapeutics, Inc. Transaction History

Wellington Management Group LLP

  • $551 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$41.44 - $59.32 $42,890 - $61,396
-1,035 Reduced 5.85%
16,654 $711,000
Q4 2022

Feb 13, 2023
SELL
$39.45 - $51.77 $42,606 - $55,911
-1,080 Reduced 5.75%
17,689 $849,000
Q3 2022

Nov 14, 2022
SELL
$27.8 - $40.12 $5,977 - $8,625
-215 Reduced 1.13%
18,769 $706,000
Q1 2022

May 16, 2022
BUY
$42.12 - $59.36 $9,561 - $13,474
227 Added 1.21%
18,984 $1.03 Million
Q4 2021

Feb 11, 2022
BUY
$36.95 - $62.89 $693,071 - $1.18 Million
18,757 New
18,757 $1.1 Million

Others Institutions Holding KROS

# of Institutions
153
Shares Held
26.7M
Call Options Held
47.6K
Put Options Held
34.5K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $1.18B
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email